Bare Financial Services
NTLA icon

Bare Financial Services’s Intellia Therapeutics NTLA Stock Holding History

Bare Financial Services’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$482 Hold
40
– – ﹤0.01% 1774
2026
Q2 		$677 Sell
40
-38
-49% -$532 ﹤0.01% 1538
2026
Q1 		$1K Buy
+78
New +$994 ﹤0.01% 1250

Other funds holding NTLA

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals Tarrytown, New York $180M AUM 18.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Canal Insurance Company
Canal Insurance Company Greenville, South Carolina $426M AUM 30.47% 1-Year Est. Return

Bare Financial Services's NTLA Position: Q3 2026 in Review

Bare Financial Services held its Intellia Therapeutics (NTLA) position steady in Q3 2026 at 40 shares worth $482. The position accounts for ﹤0.01% of the portfolio, ranked #1774.

Bare Financial Services first reported a position in NTLA in Q1 2026 and has held it in 3 quarters since. The position peaked at $1K in Q1 2026. 121 funds tracked by Wall St. Rank hold NTLA as of Q3 2026.

  • Bare Financial Services held 40 shares of Intellia Therapeutics worth $482 as of Q3 2026.
  • Bare Financial Services left its Intellia Therapeutics share count unchanged in Q3 2026.
  • Intellia Therapeutics made up ﹤0.01% of Bare Financial Services's portfolio in Q3 2026, its #1774 holding.
  • Bare Financial Services first reported a position in Intellia Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • Bare Financial Services's Intellia Therapeutics position peaked at $1K in Q1 2026.
  • 121 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q3 2026.

Based on Bare Financial Services's 13F filing for Q3 2026, filed 4 Nov 2026.